Company profile for Helix

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Helix, we’re dedicated to making DNA insights accessible and actionable for everyone. A population-scale impact We are the leading population genomics and viral surveillance company. We enable health systems, public health organizations, and life sciences companies to accelerate the integration of genomic data into patient care and public health decision making.It’s our mission to empower every person to improve their...
At Helix, we’re dedicated to making DNA insights accessible and actionable for everyone. A population-scale impact We are the leading population genomics and viral surveillance company. We enable health systems, public health organizations, and life sciences companies to accelerate the integration of genomic data into patient care and public health decision making.It’s our mission to empower every person to improve their life through DNA. We believe in a world where everyone benefits from their biological information and is able to help all of humanity lead better lives.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
San Mateo, California
Telephone
Telephone
(844) 211 - 2070
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/06/25/3105029/0/en/BioCardia-Announces-New-United-States-Patent-for-Helix-Biotherapeutic-Delivery-System.html

GLOBENEWSWIRE
25 Jun 2025

https://www.prnewswire.com/news-releases/helix-expands-pharmacogenomic-test-portfolio-to-support-safer-cancer-and-alzheimers-treatments-302466658.html

PR NEWSWIRE
28 May 2025

https://www.prnewswire.com/news-releases/helix-launches-worlds-largest-clinico-genomic-cohort-of-glp-1-agonist-treated-patients-302365649.html

PR NEWSWIRE
03 Feb 2025

https://www.prnewswire.com/news-releases/helix-debuts-novel-precision-effectiveness-model-that-predicts-12-month-weight-loss-response-of-semaglutide-in-diverse-populations-302303577.html

PR NEWSWIRE
13 Nov 2024

https://www.businesswire.com/news/home/20240624651491/en

BUSINESSWIRE
24 Jun 2024

https://www.businesswire.com/news/home/20240607081635/en

BUSINESSWIRE
07 Jun 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty